Press Release

PipelineRx Raises Over $9M in Funding to Further Accelerate Growth in Telepharmacy Market

Mitsui USA and McKesson Ventures join in latest round to fuel technology-driven services

SAN FRANCISCO, Calif.—July 7, 2015– PipelineRx, a leading medication management services and platform company focused on clinical telepharmacy, today announced a $9.1M round of funding led by Mitsui & Co. (U.S.A.), Inc. (“Mitsui USA”) and joined by McKesson Ventures and existing investor AMN Healthcare. The Company will use the investment to strengthen its technology offerings as integrated delivery networks (IDNs) and hospitals look to expand workflow models leading to better patient care, while evaluating areas of growth and opportunity. PipelineRx currently services over 200 hospitals helping them to improve medication efficacy, patient safety and satisfaction. Read more . .

About PipelineRx

PipelineRx is a leader in comprehensive medication management solutions designed to advance pharmacy towards more outcomes-focused patient care. More than 500 facilities in the U.S. and Canada depend on PipelineRx each day to process more than 20 million medication orders annually. Combining the cloud-based platform, PowerGridRx™, with expert clinical pharmacy solutions, PipelineRx delivers a holistic approach that connects patients to their medications across care settings, and helps healthcare organizations of all sizes improve patient outcomes while reducing cost. For more information about PipelineRx, please visit www.pipelinerx.com or find the company on LinkedIn, Facebook, and Twitter.